Corporate Profile
Corporate Profile
As of October 16, 2023
- Corporate Name
- EPS Corporation
- Representative
- Takehisa Yamada, Representative Director
- Headquarters
- Tsuruya Bldg., 2-23 Shimomiyabicho, Shinjuku-ku, Tokyo, Japan
TEL +81-3-5684-7797 / FAX +81-3-5804-5044 - Locations
- Tokyo/Osaka/Nagoya/Sapporo/Kawasaki
- Establishment
- July 2014
- Capital
- 100 million yen
- Business Description
-
- Sample/Reagent Management,Compound libraries
- Chemistry, Manufacturing and Control (CMC)
- Clinical Trial Planning Support, Protocol Development Support Service
- Patient Registration, Drug Randomization, Project Management Service
- CRA Service (Monitoring)
- Data Management Service
- Statistical Analysis Service
- Pharmacovigilance Service
- Medical Device Development, Regulatory Service
- Regenerative Medicine Development Support Service
- Audit Service
- Regulatory Application Support Service
- International Development, Export/Import Support Service
- Data Center Operation Service
- Employees
- 3,271 *As of October 1, 2023
- Parent Company
- EPNextS, Inc.
- Subsidiary Company
- EP Mediate Co., Ltd.
EP Yamanashi Co., Ltd. - Affiliations
-
- Clinical Data Interchange Standards Consortium
- Consortium for SS-MIX Dissemination and Promotion
- HL7 Japan
- ISPE Japan Affiliate
- Japan CRO Association
- Japan eCTD Society
- Japan Medical and Scientific Communicators Association
- Japan Pharmaceutical Industry Legal Affairs Association
- Japan Society of Clinical Trials and Research
- Japan Society of Quality Assurance
- Japanese Society for Pharmacoepidemiology
- Japanese Society of Computational Statistics
- Japanese Society of Medical Oncology
- Kansai Pharmaceutical Industries Association
- Kansai Regenerative medicine Industrial Consortium
- Pharmaceutical and Medical Device Regulatory Science Society of Japan
- The 22nd Century Cutting-Edge Medical IT Organization
- The Association of Clinical Evaluation
- The Institute for International Business Communication
- The Institute of Internal Auditors - Japan
- Union of Japanese Scientists and Engineers
Officers
Board Members and Statutory Auditors
As of November 1, 2023
- Representative Director
- Takehisa Yamada
- Representative Director
- Akira Sasa
- Board Member
- Hisayuki Yokose
- Board Member
- Noriyuki Takai
- Board Member (part-time)
- Kenichi Yamamoto
- Board Member (part-time)
- Kanami Ikeda
- Audit & Supervisory Board Member
- Masami Ito
Corporate Officers
As of October 1, 2023
- President and Representative Corporate Officer
- Takehisa Yamada
- Vice President and Corporate Officer
- Hisayuki Yokose
- Managing Corporate Officer
- Noriyuki Takai
- Senior Corporate Officer
- Riki Okubo
- Senior Corporate Officer
- Tatsuya Koishi
- Senior Corporate Officer
- Shinya Sakai
- Corporate Officer
- Risa Kawaji
- Corporate Officer
- Masanobu Yoshida
- Corporate Officer
- Chie Matsuyama
- Corporate Officer
- Mayumi Yamamoto
- Corporate Officer
- Toshiyuki Mitani
- Corporate Officer
- Yutaka Ise
- Corporate Officer
- Mari Mizukami
- Corporate Officer
- Kiyohito Fujisawa
- Corporate Officer
- Takuya Mori
Certification
| Standards | ISO 9001：2015／JIS Q 9001：2015 |  |
|---|---|---|
| Company Certified | EPS Corporation | |
| Scope | CRO service for drugs, medical devices, regenerative medicine and other products, and food for specified health use | |
| Expiry Date | Dec. 8, 2024 |
| Standards | ISO/IEC 27001：2013／JIS Q 27001：2014 |  |
|---|---|---|
| Company Certified | EPS Corporation | |
| Scope | CRO service for drugs, medical devices, regenerative medicine and other products, and food for specified health use | |
| Expiry Date | Dec. 8, 2024 |
Origin of Our Company Name
The company name EPS stands for “Ever Progressing System,” which represents our founder’s strong desire to advance forward every single day. EPS is constantly working to offer more efficient and better quality service based on knowhow developed from extensive experience in clinical trials required for drug and medical device development. We will continue to carry out this positive cycle and provide solutions as the customer’s partner.